Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesDrugs databaseBack to the home pageSearch  
Drugs database
Drugs A-Z

Brands A-Z

Drugs by categories

Drugs by manufacturer

Drugs by packager

Antibiotics for sale

Online Viagra bestellen in Nederland

Home / Drugs / Starting with E / Ephedrine
 
Ephedrine
 

An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists. [PubChem]
CategoriesVasoconstrictor Agents
Adrenergic Agents
Central Nervous System Stimulants
Sympathomimetics
PackagersAkorn Inc.
Allergy Laboratories Inc.
Ben Venue Laboratories Inc.
C.O. Truxton Inc.
Cardinal Health
Claris Lifesciences Inc.
Consolidated Midland Corp.
Ebewe Pharma
Hospira Inc.
Jordan Pharmaceuticals Inc.
Mallinckrodt Inc.
Parenta Pharmaceuticals
Pharmedium
Taylor Pharmaceuticals
West-Ward Pharmaceuticals

indication

Ephedrine commonly used as a stimulant, appetite suppressant, concentration aid, decongestant, and to treat hypotension associated with anaesthesia.

pharmacology

Ephedrine is similar in structure to the derivatives amphetamine and methamphetamine. Chemically, it is an alkaloid derived from various plants in the genus Ephedra (family Ephedraceae). It works mainly by increasing the activity of noradrenaline on adrenergic receptors.

mechanism of action

Ephedrine is a sympathomimetic amine - that is, its principal mechanism of action relies on its direct and indirect actions on the adrenergic receptor system, which is part of the sympathetic nervous system. Ephedrine increases post-synaptic noradrenergic receptor activity by (weakly) directly activating post-synaptic α-receptors and β-receptors, but the bulk of its effect comes from the pre-synaptic neuron being unable to distinguish between real adrenaline or noradrenaline from ephedrine. The ephedrine, mixed with noradrenaline, is transported through the noradrenaline reuptake complex and packaged (along with real noradrenaline) into vesicles that reside at the terminal button of a nerve cell. Ephedrine's action as an agonist at most major noradrenaline receptors and its ability to increase the release of both dopamine and to a lesser extent, serotonin by the same mechanism is presumed to have a major role in its mechanism of action.

toxicity

Cardiovascular: tachycardia, cardiac arrhythmias, angina pectoris, vasoconstriction with hypertension

absorption

85%

half life

3-6 hours

route of elimination

mainly renal

drug interactions

Amitriptyline: The tricyclic antidepressant, amitriptyline, increases the sympathomimetic effect of ephedrine.

Amoxapine: The tricyclic antidepressant, amoxapine, increases the sympathomimetic effect of ephedrine.

Clomipramine: The tricyclic antidepressant, clomipramine, increases the sympathomimetic effect of ephedrine.

Desipramine: The tricyclic antidepressant, desipramine, increases the sympathomimetic effect of ephedrine.

Desvenlafaxine: Desvenlafaxine may increase the tachycardic and vasopressor effects of ephedrine. Consider alternate therapy or monitor for increased sympathomimetic effects, such as increased blood pressure, chest pain and headache.

Doxepin: The tricyclic antidepressant, doxepin, increases the sympathomimetic effect of ephedrine.

Guanethidine: Ephedrine may decrease the effect of guanethidine.

Imipramine: The tricyclic antidepressant, imipramine, increases the sympathomimetic effect of ephedrine.

Isocarboxazid: Increased arterial pressure

Linezolid: Possible increase of arterial pressure

Methyldopa: Increased arterial pressure

Midodrine: Increased arterial pressure

Moclobemide: Moclobemide increases the sympathomimetic effect of ephedrine.

Nortriptyline: The tricyclic antidepressant, nortriptyline, increases the sympathomimetic effect of ephedrine.

Phenelzine: Increased arterial pressure

Rasagiline: Increased arterial pressure

Reserpine: Increased arterial pressure

Tranylcypromine: The MAO inhibitor, Tranylcypromine, may increase the vasopressor effect of Ephedrine. Concomitant therapy should be avoided.

Venlafaxine: Venlafaxine may increase the tachycardic and vasopressor effects of ephedrine. Consider alternate therapy or monitor for increased sympathomimetic effects, such as increased blood pressure, chest pain and headache.